Neogenomics Inc
NASDAQ:NEO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
13
20.73
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Neogenomics Inc
Neogenomics Inc
Total Current Liabilities
Neogenomics Inc
Total Current Liabilities Peer Comparison
TMO
DHR
MTD
A
IQV
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Neogenomics Inc
NASDAQ:NEO
|
Total Current Liabilities
$296.4m
|
CAGR 3-Years
47%
|
CAGR 5-Years
34%
|
CAGR 10-Years
36%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Current Liabilities
$14.6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
|
|
Danaher Corp
NYSE:DHR
|
Total Current Liabilities
$7.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Current Liabilities
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Total Current Liabilities
$2.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Current Liabilities
$7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
17%
|
See Also
What is Neogenomics Inc's Total Current Liabilities?
Total Current Liabilities
296.4m
USD
Based on the financial report for Sep 30, 2024, Neogenomics Inc's Total Current Liabilities amounts to 296.4m USD.
What is Neogenomics Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
36%
Over the last year, the Total Current Liabilities growth was 219%. The average annual Total Current Liabilities growth rates for Neogenomics Inc have been 47% over the past three years , 34% over the past five years , and 36% over the past ten years .
You don't have any saved screeners yet
